| Literature DB >> 29669288 |
Kunpeng Liu1, Chuanxia Zhang1, Bowen Li2, Weihong Xie1, Jindong Zhang1, Xichen Nie1, Peng Tan3, Limin Zheng1, Song Wu4, Yunfei Qin5, Jun Cui6, Feng Zhi7.
Abstract
p38 signaling is broadly involved in controlling inflammation and stress-induced cell death; however, the mechanisms controlling its activity have seldom been studied. Here, we report that TRIM9 short isoform (TRIM9s) potentiates p38 signaling by stabilizing MKK6. Mechanistic studies revealed that TRIM9s promotes the K63-linked ubiquitination of MKK6 at Lys82, thus inhibiting the degradative K48-linked ubiquitination of MKK6 at the same lysine. MKK6 could also stabilize TRIM9s by promoting the phosphorylation of TRIM9s at Ser76/80 via p38, thereby blocking the ubiquitin-proteasome pathway. Further functional analyses showed that p38 signaling plays a critical role in suppressing glioblastoma progression. Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. We identify a positive feedback loop in p38 signaling generated by MKK6-TRIM9s, which suppresses glioblastoma progression, and we provide insights into the mechanisms by which TRIM9s and MKK6 potentiate p38 signaling through mutual stabilization.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29669288 DOI: 10.1016/j.celrep.2018.03.096
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423